These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 10449995

  • 1. Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas.
    Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Eur Surg Res; 1999; 31(4):357-63. PubMed ID: 10449995
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma.
    Shimada H, Takeda A, Shiratori T, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Hayashi H, Gunji Y, Kobayashi S, Suzuki T, Ochiai T.
    Cancer; 2002 Apr 01; 94(7):1947-54. PubMed ID: 11932896
    [Abstract] [Full Text] [Related]

  • 3. Thymidine phosphorylase in human esophageal squamous cell carcinoma.
    Takebayashi Y, Natsugoe S, Baba M, Akiba S, Fukumoto T, Miyadera K, Yamada Y, Takao S, Akiyama S, Aikou T.
    Cancer; 1999 Jan 15; 85(2):282-9. PubMed ID: 10023693
    [Abstract] [Full Text] [Related]

  • 4. Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas.
    Okamoto E, Osaki M, Kase S, Adachi H, Kaibara N, Ito H.
    Pathol Int; 2001 Mar 15; 51(3):158-64. PubMed ID: 11328530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation between expression levels of thymidine phosphorylase (dThdPase) and clinical features in human gastric carcinoma.
    Kimura H, Konishi K, Kaji M, Maeda K, Yabushita K, Miwa A.
    Hepatogastroenterology; 2002 Mar 15; 49(45):882-6. PubMed ID: 12064013
    [Abstract] [Full Text] [Related]

  • 7. Tumor angiogenesis as an independent prognostic factor after extended radical esophagectomy for invasive squamous cell carcinoma of the esophagus.
    Nakagawa S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K.
    Surgery; 2001 Mar 15; 129(3):302-8. PubMed ID: 11231458
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus.
    Koide N, Watanabe H, Yazawa K, Adachi W, Amano J.
    Hepatogastroenterology; 1999 Mar 15; 46(26):944-51. PubMed ID: 10370644
    [Abstract] [Full Text] [Related]

  • 9. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
    Li H, Zhang Y, Cai H, Xiang J.
    Eur Surg Res; 2007 Mar 15; 39(1):1-6. PubMed ID: 17106199
    [Abstract] [Full Text] [Related]

  • 10. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
    Sun ZG, Wang Z.
    Dis Esophagus; 2011 Apr 15; 24(3):182-8. PubMed ID: 21073618
    [Abstract] [Full Text] [Related]

  • 11. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
    Sedighi M, Aledavood SA, Abbaszadegan M, Memar B, Montazer M, Rajabian M, Gholamin M.
    Asian Pac J Cancer Prev; 2016 Apr 15; 17(6):2781-5. PubMed ID: 27356690
    [Abstract] [Full Text] [Related]

  • 12. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI.
    Ann Thorac Surg; 2011 Sep 15; 92(3):1091-7. PubMed ID: 21704967
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL, Liu RL, Shi YT, Wang ZC, Wang BH, Li YJ, Zhou LY, Ping YM.
    Zhonghua Zhong Liu Za Zhi; 2009 Jul 15; 31(7):541-5. PubMed ID: 19950705
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Analysis of lymph node metastasis in the thoracic esophageal squamous cell carcinoma].
    Zhu ZJ, Zhao YF, Hu Y, Chen LQ, Liu LX, Wu Z, Kou YL, Wang Y.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 15; 30(2):138-40. PubMed ID: 18646699
    [Abstract] [Full Text] [Related]

  • 16. Nodal skip metastasis is associated with a relatively poor prognosis in thoracic esophageal squamous cell carcinoma.
    Liu J, Liu Q, Wang Y, Xia Z, Zhao G.
    Eur J Surg Oncol; 2016 Aug 15; 42(8):1202-5. PubMed ID: 27266407
    [Abstract] [Full Text] [Related]

  • 17. Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and t2-4 thoracic squamous cell esophageal cancers.
    Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, Minamiya Y, Ogawa J.
    World J Surg; 2009 Mar 15; 33(3):512-7. PubMed ID: 19009319
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
    Yang F, Zhang S, Yang H, Luo K, Wen J, Hu Y, Hu R, Huang Q, Chen J, Fu J.
    Dis Esophagus; 2015 Jul 15; 28(5):496-504. PubMed ID: 24766310
    [Abstract] [Full Text] [Related]

  • 19. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ, Hu CY, Zhang HL, He M, Meng XL, Ping YM.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 15; 29(8):604-8. PubMed ID: 18210881
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.